Clinical Trial Update: Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a combination of gemcitabine, nab-paclitaxel, and bosentan for unresectable pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)
• TRACLEER (bosentan)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 | Phase 1 | Status: RECRUITING